research communications
High-resolution Conus mucronatus
of the Mu8.1 conotoxin fromaDepartment of Biotechnology and Biomedicine, Technical University of Denmark, 2800 Kongens Lyngby, Denmark, and bDepartment of Biology, University of Copenhagen, 2200 Copenhagen, Denmark
*Correspondence e-mail: lellgaard@bio.ku.dk, premo@dtu.dk
Marine cone snails produce a wealth of peptide toxins (conotoxins) that bind their molecular targets with high selectivity and potency. Therefore, conotoxins constitute valuable biomolecular tools with a variety of biomedical purposes. The Mu8.1 conotoxin from Conus mucronatus is the founding member of the newly identified saposin-like conotoxin class of conotoxins and has been shown to target Cav2.3, a voltage-gated calcium channel. Two crystal structures have recently been determined of Mu8.1 at 2.3 and 2.1 Å resolution. Here, a high-resolution of Mu8.1 was determined at 1.67 Å resolution in the high-symmetry I4122. The contained one molecule, with a symmetry-related molecule generating a dimer equivalent to that observed in the two previously determined structures. The high resolution allows a detailed atomic analysis of a water-filled cavity buried at the dimer interface, revealing a tightly coordinated network of waters that shield a lysine residue (Lys55) with a predicted unusually low side-chain pKa value. These findings are discussed in terms of a potential functional role of Lys55 in target interaction.
Keywords: conotoxins; zinc binding; toxins; hydrogen bonding; Mu8.1.
PDB reference: Mu8.1, 8amy
1. Introduction
Animal venom ). Predatory marine cone snails produce a wide variety of venom known as conopeptides or conotoxins, with as many as 200 000 different estimated to exist in nature (Lin et al., 2021). Conotoxins are produced in the endoplasmic reticulum of cells in the cone-snail venom gland and most have a mature sequence ranging between 15 and 30 residues (Safavi-Hemami et al., 2018). Thus, like other peptide toxins, conotoxins are typically stabilized by disulfide bonds (Undheim et al., 2016). While many of these small are well characterized and known to target various cell-surface proteins, such as ion channels, different receptors and transporters, larger conotoxins (also known collectively as macro-conotoxins), such as Mu8.1 (89 residues), generally remain understudied.
and proteins constitute a rich source of bioactive compounds that are used as research tools and provide new drug candidates. Several venom have already been commercialized and used to treat a range of conditions, such as hypertension, chronic pain and thrombosis (Smallwood & Clark, 2021The great potential of conotoxins as bioactive compounds is underscored by the recent identification in cone-snail venom of nature's shortest insulin molecules (43 residues for Con-Ins G1 from Conus geographus compared with 51 residues for human insulin) that show high structural similarity to human insulin (Safavi-Hemami et al., 2015; Menting et al., 2016). These weaponized insulins can activate the human insulin receptor and lower blood glucose in zebrafish and mouse models of diabetes, indicating a potential future use as fast-acting drugs in the treatment of diabetes (Ahorukomeye et al., 2019). Another interesting class of conotoxins are the `con-ikot-ikot' toxins that inhibit the desensitization of the GluA2 AMPA receptor (AMPAR; Walker et al., 2009). This interaction has been explored by structural analysis of the of the complex between GluA2 and con-ikot-ikot from C. striatus, in turn providing new insights into receptor function (Chen et al., 2014; Baranovic et al., 2022).
Two recently published crystal structures of C. mucronatus Mu8.1 revealed an all-helical molecule forming a homodimer, with a common dimer interface observed in two different crystal conditions (Hackney et al., 2023). Dimer formation was supported by small-angle X-ray scattering (SAXS) and gel-filtration data showing that the majority of Mu8.1 also formed a stable dimer in solution. These observations suggested that dimeric Mu8.1 is likely to be of biological relevance. Each protomer in the dimer comprises five disulfide bonds connecting the four α-helices and shows structural similarity to saposin-like proteins as well as con-ikot-ikot from C. striatus (Hackney et al., 2023).
Here, we present a high-resolution I4222 at 1.67 Å resolution. The structure reveals a dimer interface equivalent to that previously observed in Mu8.1; however, in the present it is formed between two symmetry-related molecules. We further explore the water-coordinated pocket shielded by the dimer interface. The network of water molecules revealed at 1.67 Å resolution surrounds a potential functional residue, Lys55, and may contribute to the unusually low pKa value (8.16) predicted for Lys55 by PROPKA (Søndergaard et al., 2011; Olsson et al., 2011). Moreover, a surface-exposed divalent cation-binding site with a bound Zn2+ ion that mediates crystal contacts between two dimers was identified on the `backside' of Mu8.1, opposite the dimer interface.
of Mu8.1 obtained from a new crystal condition in the high-symmetry2. Materials and methods
2.1. Expression and purification of Mu8.1
Expression and purification of Mu8.1 followed the protocol described in Hackney et al. (2023). Briefly, Ub-His10-Mu8.1 was expressed from a pET-39_Ub19 vector co-transformed into Escherichia coli BL21 cells with the csCyDisCo plasmid (pLE577; Nielsen et al., 2019). Following overnight expression in auto-induction medium at 25°C, the resulting cell pellets were resuspended in 5 ml lysis buffer (50 mM Tris pH 8, 300 mM NaCl, 20 mM imidazole) per gram of cell pellet. Resuspended cells were lysed by sonication while keeping the lysate on ice throughout. Ub-His10-Mu8.1 was purified from the soluble cellular fraction by Ni–NTA immobilized metal-affinity (IMAC) using a linear elution gradient from 0% to 100% in IMAC buffer (50 mM Tris pH 8, 300 mM NaCl, 400 mM imidazole). Peak fractions were dialyzed twice against 2 l anion-exchange (AEX) buffer (50 mM NaH2PO4/Na2HPO4 pH 6.8, 20 mM NaCl) and the sample was subjected to AEX on a 10/100 Tricorn column (Cytiva) packed with Source 15Q ion-exchange resin (Amersham Biosciences, GE Healthcare). The bound protein sample was washed with 15% AEX elution buffer (50 mM NaH2PO4/Na2HPO4 pH 6.8, 1 M NaCl) until a stable UV baseline was observed. Ub-His10-Mu8.1 was then eluted over six column volumes using a gradient from 15% to 50% AEX elution buffer. The eluted fusion protein was incubated with preactivated His-tagged Tobacco etch virus (TEV) protease in a 1:20 ratio overnight at room temperature. The TEV protease-cleaved Ub-His10-Mu8.1 was subsequently loaded onto 8 ml Talon cobalt resin (Takara) pre-equilibrated in AEX buffer. The flowthrough containing untagged Mu8.1 was pooled and finally subjected to on a Superdex 75 Increase 10/300 GL column (Cytiva) pre-equilibrated in 200 mM NH4HCO3 buffer pH 7.8. Fractions containing pure Mu8.1 were pooled and lyophilized. The purity was estimated by SDS–PAGE to be >95% (Hackney et al., 2023). The final yield was estimated to be 2 mg per litre of cell culture.
2.2. Crystallization
Freeze-dried Mu8.1 was dissolved in Milli-Q ultrapure water to a concentration of 5 mg ml−1. The concentration was measured with a NanoDrop 1000 using a predicted extinction coefficient of 12 010 M−1 cm−1. Crystallization was performed by the hanging-drop vapor-diffusion method at 21°C. Drops were set up at a 1:1 ratio of reservoir solution to protein solution in a total volume of 2 µl in 24-well drop format on siliconized glass cover slides. The wells were sealed with immersion oil (Sigma–Aldrich, catalogue No. 56822) and equilibrated against 500 µl reservoir solution at 21°C. Crystals of Mu8.1 appeared in several conditions from the LMB Crystallization Screen (Molecular Dimensions, catalogue No. MD1-98; Gorrec, 2009) in a few days to weeks.
The best diffracting crystals were obtained from box 2 condition 21 of the LMB Crystallization Screen consisting of 18%(w/v) polyethylene glycol (PEG) 5000 monoethyl ether (MME), 0.2 M ammonium sulfate, 0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.5 adjusted with NaOH. Crystals were harvested using mounted CryoLoops (Hampton Research) with cryoprotection performed by quickly dipping the crystal into ∼17% ethylene glycol (Teng & Moffat, 1998) prepared by mixing 1 µl 50% ethylene glycol with 2 µl reservoir solution. The crystals were flash-cooled in liquid nitrogen and shipped to the beamline for remote data collection. Crystallization information is summarized in Table 1.
|
2.3. Data collection and processing
Diffraction data collection was carried out on the BioMax beamline at MAX IV, Lund, Sweden (Ursby et al., 2020). Data were collected at 100 K for a full sweep of 360° with an oscillation of 0.1°, with 0.011 s exposure time, at 12 700 eV. To reduce potential radiation damage, only part of the data set was processed (140°) sufficient for a highly complete data set. Data-collection and processing statistics are summarized in Table 2.
‡I/σ(I) falls below 2.0 at 1.85 Å; we used CC1/2 as an indicator of the resolution. §No anomalies were detected. |
2.4. Structure solution and refinement
The structure of Mu8.1 was determined by Phaser-MR (McCoy et al., 2007) using the recently published lower resolution of Mu8.1 as a search model (PDB entry 7px2; Hackney et al., 2023).
withModel building and phenix.refine (Adams et al., 2010) with iterative rebuilding in Coot (Emsley et al., 2010). are summarized in Table 3. Coordinates/structure factors have been submitted to the PDB with accession code 8amy.
were performed with
|
Molecular graphics were presented with the PyMOL molecular-graphics system (version 2.2r7pre; Schrödinger). Prediction of pKa values was performed by PROPKA version 3.0 (https://www.ddl.unimi.it/vegaol/propka.htm; Olsson et al., 2011; Søndergaard et al., 2011). The metal ion was identified using the metal-binding site validation server CheckMyMetal (https://cmm.minorlab.org/; Zheng et al., 2014). Mu8.1 was refined with both a Zn2+ ion and an Ni2+ ion in the surface metal site. As input, a PDB file including both the Mu8.1 coordinates and a symmetry-equivalent molecule completing the metal site were uploaded. The coordinate B factor of the metal ion, the liganding residues in the nearby environment and the tetragonal geometry were compared and all favored a Zn2+ ion (Kuppuraj et al., 2009).
3. Results and discussion
3.1. A disulfide network contributes to the rigidity of the Mu8.1 protomer
Here, we crystallized Mu8.1 in a new crystal condition and determined the structure at 1.67 Å resolution, the highest resolution reported to date. The structure was refined to a final Rwork and Rfree of 0.169 and 0.200, respectively (Table 3). MolProbity reports no Ramachandran outliers, with 96.4% of the residues in favored regions (Table 3).
The a). The first domain comprises an N-terminal 310-helix (310-N) followed by α-helix 1 (α1) and α2 (Figs. 1a and 1b). The second domain comprises α3–α4 followed by a C-terminal 310-helix (310-C). The two domains are linked by a 310-helix linker (310-L). Five disulfide bonds contribute to the overall rigidity of the toxin by forming both interdomain and intradomain connections, referred to by the roman numerals I–V. The first domain is stabilized by two disulfide bonds formed by Cys18–Cys34 (I) and Cys22–Cys30 (II), both connecting α1 and α2. In the second domain, a disulfide bond, Cys61–Cys71 (IV), connects α3 and α4 and a disulfide bond formed by Cys57–Cys89 (V) tethers the C-terminus to α3. An interdomain disulfide bond formed by Cys10–Cys51 (III) connects 310-N to α3 and contributes to the overall rigidity of Mu8.1 (Figs. 1a and 1b).
accommodates a single protomer comprising two helical `domains' that interact to form a hydrophobic core (Fig. 13.2. Lys55 at the Mu8.1 dimer interface has a low predicted pKa value
The determined structure revealed a homodimer of Mu8.1 between crystallographic symmetry-related molecules, forming a dimer interface identical to that which we previously reported in Hackney et al. (2023) (Fig. 2a). The conserved Lys55 is located at the dimer interface and is thus shielded from solvent (Fig. 2a; see further discussion below). The previously published structures (PDB entries 7px1 and 7px2; Hackney et al., 2023) accommodate one and three homodimers in the respectively. All observed homodimers form the same protomer-to-protomer orientation. Superimposition of the protomer from PDB entry 7px2 with the Mu8.1 structure reported in this work results in an r.m.s.d. of 0.69 Å for Cα atoms covering 80 residues (Fig. 2b). Due to our consistent observation of Mu8.1 in the same homodimeric conformation in three independent crystal conditions, the dimer conformation is likely to be of biological relevance.
The pKa value of ionizable side chains depends on the surrounding microenvironment. Ionizable side chains in a polar microenvironment of the protein will tend to have the same pKa as in water, while in a hydrophobic microenvironment these side-chain pKa values will tend to shift towards the neutral state (Isom et al., 2011). The Mu8.1 dimer interface is largely hydrophobic, with a pocket accommodating the strictly conserved Lys55 (Fig. 2c; Hackney et al., 2023). This feature of the structure prompted us to predict the pKa values of all charged amino-acid residues of Mu8.1 (summarized in Table S1) using the PROPKA algorithm as described in Section 2. Notably, the predicted side-chain pKa value of Lys55 (8.16) stands out as that which diverges most from the side-chain pKa of the free amino acid (10.5). The relatively low side-chain pKa could imply that Lys55 is uncharged in the dimer, thus rationalizing how it can be accommodated at the hydrophobic dimer interface.
3.3. Bifurcated hydrogen bonds may contribute to the lowered pKa value of Lys55
To determine the molecular origin of the predicted low side-chain pKa for Lys55, we inspected the structural details of the dimer interface. The high-resolution structure of Mu8.1 obtained in this work allowed us to identify a tightly coordinated hydrogen-bond network around Lys55. Several new water molecules were discovered in this higher resolution structure compared with the previous structures PDB entries 7px1 and 7px2 (Supplementary Fig. S1). Fig. 2(d) shows the electron-density map for the four water molecules refined in the vicinity of Lys55 in the high-resolution structure. Here, Lys55 shows fully saturated hydrogen-bond formation with two water molecules (w1 and w2) and the side-chain hydroxyl group of Thr35 (Fig. 2e). The water networks extends from w2 to waters w3 and w4. Water w3 is also coordinated by the carbonyl groups in the backbones of Cys10 and Thr46. Water w4 forms hydrogen bonds to the hydroxy group of Thr46, the side-chain amide of Asn47 and the backbone carbonyl of Thr35. The latter residue forms a bifurcated hydrogen bond with the backbone carbonyl group of Tyr31. Four additional threonine residues (Thr36, Thr39, Thr52 and Thr56) are found within the otherwise nonpolar dimer interface. All five threonine residues form bifurcated hydrogen bonds from their side-chain OH group to the backbone carbonyl group of the residue at position i + 4 relative to the threonine. Thus, these five threonine residues act as donors, while the residues found at the i + 4 helical position, Tyr31, Ala32, Thr35, Arg48 and Thr52, act as acceptors (Fig. 2e). All five threonine residues are trapped in the +gauche conformation with an χ1 angle close to −60°, as expected for this type of interaction (Feldblum & Arkin, 2014). This type of bifurcated hydrogen bonding is particularly strong (Feldblum & Arkin, 2014) and has previously been suggested to allow threonine and serine residues to reside in transmembrane α-helices (Engelman & Steitz, 1981). Moreover, we noticed π–π stacking of the aromatic rings of Tyr31 and Phe15 (Fig. 2e). Overall, we propose that the combination of this side-chain stacking and the observed hydrogen-bonding network creates a hydrophobic microenvironment surrounding Lys55 that results in a lowering of the pKa of its ɛ-amino group.
3.4. A Zn2+ ion-binding site mediates crystal contacts between two Mu8.1 dimers
The present high-resolution 2+) ion-binding site (Fig. 3a). The putative Zn2+ ion is located on the surface of the first domain (α1 and α2) and mediates a crystal contact between equivalent sites in a symmetry-related molecule that differs from the previously described dimer interface (Fig. 3a). The divalent cation ion is coordinated by His42 and Glu14 in a classical tetrahedral geometry, with coordination distances corresponding to a Zn2+ site (Fig. 3b; Alberts et al., 1998). The previously determined structure of Mu8.1 (PDB entry 7px1; Hackney et al., 2023) included divalent binding sites for Cd2+ ions, which were introduced from the crystallization conditions and were located at equivalent positions to the metal site presented here (Hackney et al., 2023). However, no additional divalent ions were added in the present crystallization conditions, and hence the observed metal ion must have been carried along in the purification process: either a cytoplasmic Zn2+ ion or an Ni2+ ion originating from the Ni–NTA purification step. The complex coordination and the metal–ligand distances are equivalent to the typical tetrahedral coordination found for a Zn2+ site in biological molecules (Dudev & Lim, 2000; Kuppuraj et al., 2009). It is therefore likely that a Zn2+ ion chelates to the surface of Mu8.1 under physiological conditions. In connection to this, we note that previous dose–response experiments performed on HEK293 cells transiently overexpressing Cav2.3 revealed that trace metals, including Zn2+ and Cu2+, modulate the voltage-dependent gating of Cav2.3, with reported IC50 values of 1.3 µM and 18.2 nM, respectively (Shcheglovitov et al., 2012). The ability of Mu8.1 to coordinate Zn2+ may therefore comprise an additional level of regulation in terms of Cav2.3 inhibition. Still, a potential physiological function for Zn2+ binding by Mu8.1 remains speculative.
of Mu8.1 also revealed a possible zinc (Zn3.5. Implications of the Mu8.1 structure for target interactions
The current findings have implications for Mu8.1 target interactions. The consistent observation of Mu8.1 in identical homodimeric crystal conformations suggests that this dimer is of biological relevance. In connection to this, we propose that the bifurcated hydrogen bonds formed by threonine residues at the dimer interface and the water network formed around Lys55 contribute to the hydrophobicity observed at the dimer interface. Analytical gel-filtration and SAXS data also show that Mu8.1 exists as a dimer in solution at concentrations above 1 µM (Hackney et al., 2023). With interaction studies between Mu8.1 and Cav2.3 conducted at concentrations of 1– 10 µM (Hackney et al., 2023), binding to this target is likely to take place in the dimeric state.
Still, it cannot be ruled out that Mu8.1 may bind targets (for example if other physiological targets exist in addition to Cav2.3) in a monomeric state. A potential indication of this binding mode comes from an analysis of the interaction between con-ikot-ikot and AMPAR. As described in Hackney et al. (2023), Mu8.1 shows high structural similarity to con-ikot-ikot. Despite the lack of AMPAR binding by Mu8.1 (Hackney et al., 2023), we hypothesized that the structural resemblance to con-ikot-ikot may predict the region of Mu8.1 that is involved in target binding. Thus, we superimposed Mu8.1 with con-ikot-ikot as observed in complex with AMPAR (PDB entry 4u5b; Chen et al., 2014; Supplementary Fig. S2). This analysis revealed that the hydrophobic interface of Mu8.1, which is shielded in the dimer, is equivalent to the face of con-ikot-ikot involved in AMPAR binding. Provided that the dimer interface is involved in target binding in a monomeric state, a functional role of Lys55 can be envisaged in which a conformational change in the protein would result in the side chain acquiring a full positive charge for electrostatic interaction with the target. This scenario would not be unusual, given that charged residues located in a pocket or in the hydrophobic interior of a protein, such as Lys55, often serve a functional role in protein–protein interactions (or as catalytic residues because of increased reactivity; Isom et al., 2011; Hacker et al., 2017). Moreover, conversion from an inactive dimer to an active monomer formed through mechanisms involving, for example, proteolytic cleavage, dilution or membrane interaction has been observed for other toxins, such as the aerolysin toxin from Aeromonas hydrophila (Fivaz et al., 1999) and phospholipase A2 from Bothrops jararacussu venom (Ruller et al., 2003). If a dimer–monomer equilibrium indeed regulates Mu8.1 target binding, monomerization could for instance be induced by specific physiological conditions in the prey or by a concentration-dependent mechanism (i.e. dilution).
Overall, the present structure provides detailed insight into several features of the Mu8.1 dimer interface, with implications for target interactions. Future investigations will be aimed at discerning the exact binding mode of Mu8.1, for example through co-crystallization or docking studies.
Supporting information
PDB reference: Mu8.1, 8amy
Supplemetary Table and Figures. DOI: https://doi.org/10.1107/S2053230X23007070/ow5036sup1.pdf
Acknowledgements
We acknowledge the MAX IV Laboratory for time on the BioMax beamline under Proposal 20190343. We thank Dr Uwe Müller for assistance during data collection.
Funding information
Funding was obtained from the Independent Research Fund Denmark, Technology and Production Sciences (Grant No. 7017-00288 to LE).
References
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C. & Zwart, P. H. (2010). Acta Cryst. D66, 213–221. Web of Science CrossRef CAS IUCr Journals Google Scholar
Ahorukomeye, P., Disotuar, M. M., Gajewiak, J., Karanth, S., Watkins, M., Robinson, S. D., Flórez Salcedo, P., Smith, N. A., Smith, B. J., Schlegel, A., Forbes, B. E., Olivera, B., Chou, D. H.-C. & Safavi-Hemami, H. (2019). eLife, 8, e41574. CrossRef PubMed Google Scholar
Alberts, I. L., Nadassy, K. & Wodak, S. J. (1998). Protein Sci. 7, 1700–1716. Web of Science CrossRef PubMed CAS Google Scholar
Baranovic, J., Braunbeck, S., Zaki, N., Minniberger, S., Chebli, M. & Plested, A. J. R. (2022). J. Gen. Physiol. 154, e202112912. CrossRef PubMed Google Scholar
Casanas, A., Warshamanage, R., Finke, A. D., Panepucci, E., Olieric, V., Nöll, A., Tampé, R., Brandstetter, S., Förster, A., Mueller, M., Schulze-Briese, C., Bunk, O. & Wang, M. (2016). Acta Cryst. D72, 1036–1048. Web of Science CrossRef IUCr Journals Google Scholar
Chen, L., Dürr, K. L. & Gouaux, E. (2014). Science, 345, 1021–1026. CrossRef CAS PubMed Google Scholar
Dudev, T. & Lim, C. (2000). J. Am. Chem. Soc. 122, 11146–11153. Web of Science CrossRef CAS Google Scholar
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. Web of Science CrossRef CAS IUCr Journals Google Scholar
Engelman, D. M. & Steitz, T. A. (1981). Cell, 23, 411–422. CrossRef CAS PubMed Google Scholar
Feldblum, E. S. & Arkin, I. T. (2014). Proc. Natl Acad. Sci. USA, 111, 4085–4090. Web of Science CrossRef CAS PubMed Google Scholar
Fivaz, M., Velluz, M.-C. & van der Goot, F. G. (1999). J. Biol. Chem. 274, 37705–37708. CrossRef PubMed CAS Google Scholar
Gorrec, F. (2009). J. Appl. Cryst. 42, 1035–1042. Web of Science CrossRef CAS IUCr Journals Google Scholar
Hacker, S. M., Backus, K. M., Lazear, M. R., Forli, S., Correia, B. E. & Cravatt, B. F. (2017). Nat. Chem. 9, 1181–1190. CrossRef CAS PubMed Google Scholar
Hackney, C. M., Flórez Salcedo, P., Mueller, E., Koch, T. L., Kjelgaard, L. D., Watkins, M., Zachariassen, L., Tuelund, P. S., McArthur, J. R., Adams, D. J., Kristensen, A. S., Olivera, B., Finol-Urdaneta, R. K., Safavi-Hemami, H., Morth, J. P. & Ellgaard, L. (2023). PLoS Biol. 21, e3002217. CrossRef PubMed Google Scholar
Isom, D. G., Castañeda, C. A., Cannon, B. R. & García-Moreno, E. B. (2011). Proc. Natl Acad. Sci. USA, 108, 5260–5265. CrossRef CAS PubMed Google Scholar
Kuppuraj, G., Dudev, M. & Lim, C. (2009). J. Phys. Chem. B, 113, 2952–2960. Web of Science CrossRef PubMed CAS Google Scholar
Lin, Z., Torres, J. P., Watkins, M., Paguigan, N., Niu, C., Imperial, J. S., Tun, J., Safavi-Hemami, H., Finol-Urdaneta, R. K., Neves, J. L. B., Espino, S., Karthikeyan, M., Olivera, B. M. & Schmidt, E. W. (2021). Front. Pharmacol. 12, 655981. CrossRef PubMed Google Scholar
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. Web of Science CrossRef CAS IUCr Journals Google Scholar
Menting, J. G., Gajewiak, J., MacRaild, C. A., Chou, D. H.-C., Disotuar, M. M., Smith, N. A., Miller, C., Erchegyi, J., Rivier, J. E., Olivera, B. M., Forbes, B. E., Smith, B. J., Norton, R. S., Safavi-Hemami, H. & Lawrence, M. C. (2016). Nat. Struct. Mol. Biol. 23, 916–920. CrossRef CAS PubMed Google Scholar
Nielsen, L. D., Foged, M. M., Albert, A., Bertelsen, A. B., Søltoft, C. L., Robinson, S. D., Petersen, S., Purcell, A. W., Olivera, B. M., Norton, R. S., Vasskog, T., Safavi-Hemami, H., Teilum, K. & Ellgaard, L. (2019). J. Biol. Chem. 294, 8745–8759. CrossRef CAS PubMed Google Scholar
Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M. & Jensen, J. H. (2011). J. Chem. Theory Comput. 7, 525–537. Web of Science CrossRef CAS PubMed Google Scholar
Ruller, R., Ferreira, T. L., de Oliveira, A. H. C. & Ward, R. J. (2003). Arch. Biochem. Biophys. 411, 112–120. CrossRef PubMed CAS Google Scholar
Safavi-Hemami, H., Foged, M. M. & Ellgaard, L. (2018). Oxidative Folding of Proteins: Basic Principles, Cellular Regulation and Engineering, edited by M. J. Feige, pp. 99–128. Cambridge: Royal Society of Chemistry. Google Scholar
Safavi-Hemami, H., Gajewiak, J., Karanth, S., Robinson, S. D., Ueberheide, B., Douglass, A. D., Schlegel, A., Imperial, J. S., Watkins, M., Bandyopadhyay, P. K., Yandell, M., Li, Q., Purcell, A. W., Norton, R. S., Ellgaard, L. & Olivera, B. M. (2015). Proc. Natl Acad. Sci. USA, 112, 1743–1748. CAS PubMed Google Scholar
Shcheglovitov, A., Vitko, I., Lazarenko, R. M., Orestes, P., Todorovic, S. M. & Perez-Reyes, E. (2012). J. Gen. Physiol. 139, 219–234. CrossRef CAS PubMed Google Scholar
Smallwood, T. B. & Clark, R. J. (2021). Exp. Opin. Drug. Discov. 16, 1163–1173. CrossRef CAS Google Scholar
Søndergaard, C. R., Olsson, M. H. M., Rostkowski, M. & Jensen, J. H. (2011). J. Chem. Theory Comput. 7, 2284–2295. Web of Science PubMed Google Scholar
Teng, T.-Y. & Moffat, K. (1998). J. Appl. Cryst. 31, 252–257. Web of Science CrossRef CAS IUCr Journals Google Scholar
Undheim, E. A. B., Mobli, M. & King, G. F. (2016). BioEssays, 38, 539–548. CrossRef CAS PubMed Google Scholar
Ursby, T., Åhnberg, K., Appio, R., Aurelius, O., Barczyk, A., Bartalesi, A., Bjelčić, M., Bolmsten, F., Cerenius, Y., Doak, R. B., Eguiraun, M., Eriksson, T., Friel, R. J., Gorgisyan, I., Gross, A., Haghighat, V., Hennies, F., Jagudin, E., Norsk Jensen, B., Jeppsson, T., Kloos, M., Lidon-Simon, J., de Lima, G. M. A., Lizatovic, R., Lundin, M., Milan-Otero, A., Milas, M., Nan, J., Nardella, A., Rosborg, A., Shilova, A., Shoeman, R. L., Siewert, F., Sondhauss, P., Talibov, V. O., Tarawneh, H., Thånell, J., Thunnissen, M., Unge, J., Ward, C., Gonzalez, A. & Mueller, U. (2020). J. Synchrotron Rad. 27, 1415–1429. Web of Science CrossRef CAS IUCr Journals Google Scholar
Walker, C. S., Jensen, S., Ellison, M., Matta, J. A., Lee, W. Y., Imperial, J. S., Duclos, N., Brockie, P. J., Madsen, D. M., Isaac, J. T. R., Olivera, B. & Maricq, A. V. (2009). Curr. Biol. 19, 900–908. CrossRef PubMed CAS Google Scholar
Zheng, H., Chordia, M. D., Cooper, D. R., Chruszcz, M., Müller, P., Sheldrick, G. M. & Minor, W. (2014). Nat. Protoc. 9, 156–170. Web of Science CrossRef CAS PubMed Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.